dallas-mcmillan

About Dallas McMillan

Dallas McMillan is founder and President of Rhizo Sciences and leads the international hemp and cannabis activities. Recognised as a leading authority in production of truly medical grade cannabis, Dallas leads a team of agricultural, medical and pharmaceutical specialists with a passion for cannabis and hemp and the impact they can make on human health, the environment, and economies. Key to Rhizo Sciences' success in the industry has been an emphasis on leveraging proven technology, personnel and processes from traditional industries while honoring the unique value and characteristics of the cannabis plant and those who have worked tirelessly to bring it into the mainstream. Connect with Dallas on Linkedin or Email.

CBD Isolate Drug Epidiolex Approved by FDA

Epidiolex, a new pharmaceutical drug containing CBD Isolate opens up [...]

By |2019-03-10T03:01:17+00:00March 8, 2019|Categories: CBD|Tags: , , , , , , , , , , |Comments Off on CBD Isolate Drug Epidiolex Approved by FDA

Pharmaceutical Grade Cannabinoids for Clinical Trials

Why Pharmaceutical Grade Cannabinoids Are Needed for Clinical Trials Recently, [...]

By |2018-10-06T08:43:36+00:00October 6, 2018|Categories: Medical Cannabis|Tags: , , , , , , , , , |Comments Off on Pharmaceutical Grade Cannabinoids for Clinical Trials

Title

Go to Top